U.S. PHARMACOPEIA

Search USP29  
Hyoscyamine Sulfate Injection
» Hyoscyamine Sulfate Injection is a sterile solution of Hyoscyamine Sulfate in Water for Injection. It contains not less than 93.0 percent and not more than 107.0 percent of the labeled amount of hyoscyamine sulfate [(C17H23NO3)2·H2SO4·2H2O].
Packaging and storage— Preserve in single-dose or multiple-dose containers, preferably of Type I glass, and store at controlled room temperature.
Identification—
A: Transfer a volume of Injection, equivalent to about 2.5 mg of hyoscyamine sulfate, to a separator. Render alkaline with 6 N ammonium hydroxide, and extract with 25 mL of methylene chloride, filtering the extract into a beaker. Evaporate to dryness. Add 2 drops of nitric acid to the dry residue, and evaporate on a steam bath to dryness. Add a few drops of alcoholic potassium hydroxide TS: a violet color is produced.
B: Transfer a volume of Injection, equivalent to about 2.5 mg of hyoscyamine sulfate, to a separator. Render the solution acidic with 3 N sulfuric acid, and extract with 30 mL of methylene chloride. Discard the extract. Render the solution alkaline with 6 N ammonium hydroxide, and extract with 30 mL of methylene chloride, filtering the extract into a beaker. Evaporate to dryness. Dissolve the residue in a small amount of 0.1 N hydrochloric acid, and add gold chloride TS, with shaking, until a definite precipitate separates. Heat until the precipitate dissolves, and allow the solution to cool: lustrous golden yellow scales are formed.
C: After evaporation to dryness, or appropriate adjustment of concentration, it responds to the tests for Sulfate 191.
D: The angular rotation of the Injection is levorotatory.
Bacterial endotoxins 85 It contains not more than 714.3 USP Endotoxin Units per mg of hyoscyamine sulfate.
pH 791: between 3.0 and 6.5.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Other requirements— It meets the requirements under Injections 1.
Assay—
Diluent— Use 0.01 N hydrochloric acid.
Buffer solution— Transfer 13.6 g of monobasic potassium phosphate to a 2000-mL volumetric flask, dissolve in about 1800 mL of water, adjust with phosphoric acid to a pH of 3.0 ± 0.1, dilute with water to volume, mix, and filter.
Mobile phase— With continuous stirring, add 0.3 mL of triethylamine to 1800 mL of the Buffer solution. Add 200 mL of acetonitrile, mix well, and degas.
Standard stock preparation— Dissolve an accurately weighed quantity of USP Hyoscyamine Sulfate RS in Diluent to obtain a solution having a concentration of about 0.16 mg of anhydrous hyoscyamine sulfate per mL. [NOTE—This solution may be stored in a refrigerator for 30 days.]
Standard preparation— Transfer 3.0 mL of the Standard stock preparation into a 100-mL volumetric flask, dilute with Diluent, to volume and mix. Calculate the concentration, C, in mg per mL, of anhydrous hyoscyamine sulfate in this solution.
Assay preparation— Transfer an accurately measured volume of Injection, equivalent to about 1.0 mg of hyoscyamine sulfate, to a 200-mL volumetric flask, dilute with Diluent to volume, and mix. Pass an aliquot through a 0.45-µm filter, discarding the first 5 mL of the filtrate.
Chromatographic system— The liquid chromatograph is equipped with a 205-nm detector and a 4.6-mm × 15-cm column that contains 4-µm packing L11 and a 3-mm × 4-mm guard column that contains packing L11. The flow rate is about 1.0 mL per minute. The column temperature is maintained at 30. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the tailing factor is not more than 1.8, and the relative standard deviation for six replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 50 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the area responses for the major peaks. Calculate the quantity, in mg, of hyoscyamine sulfate [(C17H23NO3)2·H2SO4·2H2O] in each mL of the Injection taken by the formula:
100 × 1.053 × (C/V)(rU / rS),
in which 1.053 is the ratio of the molecular weight of hydrated hyoscyamine sulfate to that of anhydrous hyoscyamine sulfate; C is as defined under Standard preparation; V is the volume, in mL, of Injection taken; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Elena Gonikberg, Ph.D., Scientist
Expert Committee : (MDGRE05) Monograph Development-Gastrointestinal Renal and Endocrine
USP29–NF24 Page 1096
Pharmacopeial Forum : Volume No. 31(5) Page 1373
Phone Number : 1-301-816-8251